Variant report

Variant	nsv521598
Chromosome Location	chr9:6142157-6291125
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:6236398-6236588	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:6272234-6272566	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:6197394-6197552	HepG2	liver:	n/a	n/a
4	ARID3A	chr9:6236968-6237134	HepG2	liver:	n/a	n/a
5	ARID3A	chr9:6238753-6239428	HepG2	liver:	n/a	n/a
6	ATF2	chr9:6184965-6185468	GM12878	blood:	n/a	n/a
7	ATF2	chr9:6197314-6197660	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF2	chr9:6184846-6185494	GM12878	blood:	n/a	n/a
9	BACH1	chr9:6212812-6213039	K562	blood:	n/a	n/a
10	BATF	chr9:6243774-6244147	GM12878	blood:	n/a	chr9:6243981-6243992
11	BATF	chr9:6184773-6185635	GM12878	blood:	n/a	n/a
12	BATF	chr9:6243750-6244097	GM12878	blood:	n/a	chr9:6243981-6243992
13	BATF	chr9:6185007-6185418	GM12878	blood:	n/a	n/a
14	BATF	chr9:6186725-6187026	GM12878	blood:	n/a	n/a
15	BCL11A	chr9:6185090-6185360	GM12878	blood:	n/a	n/a
16	BCL11A	chr9:6243799-6244059	GM12878	blood:	n/a	n/a
17	BCL11A	chr9:6185001-6185445	GM12878	blood:	n/a	n/a
18	BCLAF1	chr9:6184828-6185523	GM12878	blood:	n/a	n/a
19	BHLHE40	chr9:6243865-6244064	GM12878	blood:	n/a	n/a
20	BHLHE40	chr9:6238901-6239586	HepG2	liver:	n/a	n/a
21	BRCA1	chr9:6218063-6218503	Hela-S3	cervix:	n/a	n/a
22	BRCA1	chr9:6238263-6238286	Hela-S3	cervix:	n/a	n/a
23	BRCA1	chr9:6215680-6215690	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr9:6152733-6153851	Hela-S3	cervix:	n/a	n/a
25	CBX3	chr9:6173885-6174320	HCT-116	colon:	n/a	n/a
26	CBX3	chr9:6173953-6174243	K562	blood:	n/a	n/a
27	CBX3	chr9:6173999-6174182	K562	blood:	n/a	n/a
28	CEBPB	chr9:6272120-6272628	IMR90	lung:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
29	CEBPB	chr9:6183141-6183440	HepG2	liver:	n/a	n/a
30	CEBPB	chr9:6218092-6218568	ECC-1	luminal epithelium:	n/a	n/a
31	CEBPB	chr9:6143197-6143342	A549	lung:	n/a	n/a
32	CEBPB	chr9:6236340-6237204	HepG2	liver:	n/a	chr9:6237021-6237032 chr9:6236490-6236503 chr9:6236490-6236501
33	CEBPB	chr9:6277384-6277810	A549	lung:	n/a	chr9:6277616-6277627
34	CEBPB	chr9:6184889-6184892	Hela-S3	cervix:	n/a	n/a
35	CEBPB	chr9:6217956-6218616	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr9:6272126-6272623	A549	lung:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
37	CEBPB	chr9:6277436-6277905	A549	lung:	n/a	chr9:6277616-6277627
38	CEBPB	chr9:6277440-6277797	A549	lung:	n/a	chr9:6277616-6277627
39	CEBPB	chr9:6158109-6158188	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr9:6272151-6272635	Hela-S3	cervix:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
41	CEBPB	chr9:6201277-6201513	A549	lung:	n/a	n/a
42	CEBPB	chr9:6272287-6272514	HepG2	liver:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
43	CEBPB	chr9:6201283-6201500	HepG2	liver:	n/a	n/a
44	CEBPB	chr9:6272124-6272587	HepG2	liver:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
45	CEBPB	chr9:6188983-6189211	HepG2	liver:	n/a	n/a
46	CEBPB	chr9:6272208-6272574	HepG2	liver:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
47	CEBPB	chr9:6277414-6277814	Hela-S3	cervix:	n/a	chr9:6277616-6277627
48	CEBPB	chr9:6277433-6277801	ECC-1	luminal epithelium:	n/a	chr9:6277616-6277627
49	CEBPB	chr9:6277431-6277784	MCF-7	breast:	n/a	chr9:6277616-6277627
50	CEBPB	chr9:6192796-6192849	HepG2	liver:	n/a	chr9:6192835-6192846

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:6241371-6241421	NH-A	brain:	n/a
2	chr9:6252007-6252057	GM06990	blood:	n/a
3	chr9:6241371-6241421	GM12891	blood:	n/a
4	chr9:6252007-6252057	AG04449	skin:	fetal
5	chr9:6252007-6252057	HL-60	blood:	n/a
6	chr9:6241371-6241421	NHDF-neo	bronchial:	n/a
7	chr9:6241371-6241421	NB4	blood:	n/a
8	chr9:6241371-6241421	AG09319	gingival:	n/a
9	chr9:6252007-6252057	ovcar-3	ovarian:	n/a
10	chr9:6241371-6241421	SK-N-MC	brain:	n/a
11	chr9:6252007-6252057	Hela-S3	cervix:	n/a
12	chr9:6241371-6241421	GM12878	blood:	n/a
13	chr9:6252007-6252057	HEK293	kidney:	embryo
14	chr9:6252007-6252057	HPAEpiC	pulmonary alveolar:	n/a
15	chr9:6241371-6241421	BE2_C	brain:	n/a
16	chr9:6241371-6241421	HPAEpiC	pulmonary alveolar:	n/a
17	chr9:6252007-6252057	AG09319	gingival:	n/a
18	chr9:6252007-6252057	AG10803	skin:	n/a
19	chr9:6252007-6252057	HRE	kidney:	n/a
20	chr9:6252007-6252057	HCM	heart:	n/a
21	chr9:6252007-6252057	SK-N-SH	brain:	n/a
22	chr9:6252007-6252057	GM12891	blood:	n/a
23	chr9:6252007-6252057	A549	lung:	n/a
24	chr9:6252007-6252057	AG04450	lung:	fetal
25	chr9:6241371-6241421	AoSMC	blood vessel:	n/a
26	chr9:6252007-6252057	Jurkat	blood:	n/a
27	chr9:6241371-6241421	HL-60	blood:	n/a
28	chr9:6252007-6252057	GM12892	blood:	n/a
29	chr9:6252007-6252057	BJ	skin:	n/a
30	chr9:6241371-6241421	HAEpiC	amniotic membrane:	n/a
31	chr9:6252007-6252057	PFSK-1	brain:	n/a
32	chr9:6252007-6252057	PrEC	prostate:	n/a
33	chr9:6241371-6241421	HRCEpiC	kidney:	n/a
34	chr9:6252007-6252057	PANC-1	pancreas:	n/a
35	chr9:6241371-6241421	SK-N-SH	brain:	n/a
36	chr9:6241371-6241421	MCF10A-Er-Src	breast:	n/a
37	chr9:6252007-6252057	HCPEpiC	choroid plexus:	n/a
38	chr9:6241371-6241421	HIPEpiC	eye:	n/a
39	chr9:6241371-6241421	NHBE	bronchial:	n/a
40	chr9:6241371-6241421	RPTEC	kidney:	n/a
41	chr9:6252007-6252057	NHBE	bronchial:	n/a
42	chr9:6241371-6241421	HNPCEpiC	eye:	n/a
43	chr9:6252007-6252057	ProgFib	skin:	n/a
44	chr9:6241371-6241421	HepG2	liver:	n/a
45	chr9:6252007-6252057	NH-A	brain:	n/a
46	chr9:6252007-6252057	SKMC	muscle:	n/a
47	chr9:6252007-6252057	SK-N-SH_RA	brain:	n/a
48	chr9:6252007-6252057	Caco-2	colon:	n/a
49	chr9:6241371-6241421	AG04450	lung:	fetal
50	chr9:6252007-6252057	H1-hESC	embryonic stem cell:	embryo

No.	Distal block	Cell Line	Cell type
1	chr9:6266181..6268457-chr9:6269163..6272196,3	K562	blood:
2	chr9:6149075..6150608-chr9:6166608..6168151,2	MCF-7	breast:
3	chr9:6241308..6243910-chr9:6245192..6247268,2	MCF-7	breast:
4	chr9:6149075..6150608-chr9:6166608..6168151,2	MCF-7	breast:
5	chr9:6163920..6166108-chr9:6170937..6173147,2	MCF-7	breast:
6	chr9:6196840..6197620-chr9:6306018..6306519,2	MCF-7	breast:
7	chr9:6163920..6166108-chr9:6170937..6173147,2	MCF-7	breast:
8	chr9:6244528..6246233-chr9:6251156..6253683,2	MCF-7	breast:
9	chr9:6163367..6165821-chr9:6169712..6171511,2	K562	blood:
10	chr9:6201029..6203540-chr9:6215680..6218483,2	K562	blood:
11	chr9:6244528..6246233-chr9:6251156..6253683,2	MCF-7	breast:
12	chr9:6195102..6195794-chr9:6568308..6568912,2	K562	blood:
13	chr9:6234179..6236096-chr9:6238826..6241061,2	K562	blood:
14	chr9:6182316..6185009-chr9:6186082..6187902,2	K562	blood:
15	chr9:6174199..6177048-chr9:6181572..6183383,2	MCF-7	breast:
16	chr9:6163094..6165877-chr9:6167250..6170974,4	K562	blood:
17	chr9:6163094..6165877-chr9:6167250..6170974,4	K562	blood:
18	chr9:6194592..6195131-chr9:6305762..6306590,2	MCF-7	breast:
19	chr9:6174199..6177048-chr9:6181572..6183383,2	MCF-7	breast:
20	chr9:6182316..6185009-chr9:6186082..6187902,2	K562	blood:
21	chr9:6266181..6268457-chr9:6269163..6272196,3	K562	blood:
22	chr9:6163367..6165821-chr9:6169712..6171511,2	K562	blood:
23	chr9:6234179..6236096-chr9:6238826..6241061,2	K562	blood:
24	chr13:43706108..43706705-chr9:6170816..6171542,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TPD52L3-1	chr9:6241693-6241785	NONHSAT130126
2	lnc-IL33-2	chr9:6195934-6196846	NONHSAT130125
3	lnc-TPD52L3-1	chr9:6242192-6242734	NONHSAT130126
4	lnc-IL33-2	chr9:6197158-6197248	NONHSAT130125
5	lnc-IL33-1	chr9:6276640-6276974	NONHSAT130127

Variant related genes	Relation type
ENSG00000237274	TF binding region
IL33	TF binding region
ENSG00000233846	TF binding region
ENSG00000228132	TF binding region
ENSG00000237274	CpG island
IL33	CpG island
ENSG00000233846	CpG island
ENSG00000228132	CpG island
ENSG00000137033	chromatin interactions
ENSG00000237158	chromatin interactions

Extended variants
information (count: 5698 )
Associated
traits (count: 104 )

Variant overlapped rSNPs/rCNVs (count:5698 , 50 per page) page: 1 2 3 4 5 6 7 ... 114

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs544253	chr9:6142157-6142158	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs111995922	chr9:6142197-6142198	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs542439343	chr9:6142242-6142243	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs560518933	chr9:6142262-6142263	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs72699174	chr9:6142329-6142330	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs376101566	chr9:6142373-6142374	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs147480253	chr9:6142392-6142393	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs370432564	chr9:6142403-6142404	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs569878259	chr9:6142415-6142416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs140026773	chr9:6142416-6142417	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs394879	chr9:6142418-6142419	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs532167481	chr9:6142433-6142434	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs555643025	chr9:6142437-6142438	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs75092919	chr9:6142456-6142457	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs145501958	chr9:6142488-6142489	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs565781107	chr9:6142543-6142544	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs529941242	chr9:6142544-6142545	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs548406028	chr9:6142575-6142576	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs566557771	chr9:6142578-6142579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs533938429	chr9:6142607-6142608	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs144341918	chr9:6142623-6142624	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs570576291	chr9:6142645-6142646	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs10975460	chr9:6142674-6142675	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs556119532	chr9:6142750-6142751	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs77933916	chr9:6142759-6142760	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs188591104	chr9:6142770-6142771	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs374867936	chr9:6142811-6142812	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs530659589	chr9:6142826-6142827	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs148790218	chr9:6142901-6142902	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs413382	chr9:6142948-6142949	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs373981761	chr9:6142979-6142980	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs76623319	chr9:6143026-6143027	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs536670673	chr9:6143032-6143033	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs62558401	chr9:6143051-6143052	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs546350780	chr9:6143058-6143059	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs557611562	chr9:6143079-6143080	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs558701974	chr9:6143082-6143083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs142446709	chr9:6143145-6143146	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs151335721	chr9:6143157-6143158	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs139030450	chr9:6143170-6143171	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs368516451	chr9:6143180-6143181	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs144014197	chr9:6143186-6143187	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs180726050	chr9:6143190-6143191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs560365065	chr9:6143215-6143216	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs146440138	chr9:6143243-6143244	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs560669138	chr9:6143244-6143245	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs140915501	chr9:6143252-6143253	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs185988888	chr9:6143282-6143283	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs531691033	chr9:6143284-6143285	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs549805031	chr9:6143287-6143288	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:104)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Developmental delay	21147756	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metastatic melanoma	18483359	CNVD
Glioblastoma	19074898	CNVD
Malignant melanoma	19074898	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Schizophrenia	23813976	CNVD
Melanoma	20877625	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:850 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:6135600-6152800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr9:6142200-6142600	Enhancers	Liver	Liver
3	chr9:6142200-6144000	Enhancers	Stomach Mucosa	stomach
4	chr9:6142600-6143000	Flanking Active TSS	Liver	Liver
5	chr9:6142600-6143000	Enhancers	Gastric	stomach
6	chr9:6142600-6144000	Enhancers	Esophagus	oesophagus
7	chr9:6142600-6144000	Enhancers	Pancreas	Pancrea
8	chr9:6142800-6143200	Enhancers	HepG2	liver
9	chr9:6143000-6143400	Enhancers	Liver	Liver
10	chr9:6143000-6149400	Weak transcription	Gastric	stomach
11	chr9:6143400-6143600	Flanking Active TSS	Liver	Liver
12	chr9:6143600-6144200	Enhancers	Liver	Liver
13	chr9:6146800-6148600	Enhancers	Hela-S3	cervix
14	chr9:6147200-6147800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
15	chr9:6147600-6150200	Enhancers	HUVEC	blood vessel
16	chr9:6147800-6153800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
17	chr9:6148600-6149600	Weak transcription	Hela-S3	cervix
18	chr9:6149200-6149600	Enhancers	Left Ventricle	heart
19	chr9:6149400-6149800	ZNF genes & repeats	Gastric	stomach
20	chr9:6149600-6151600	Enhancers	Hela-S3	cervix
21	chr9:6149800-6153800	Weak transcription	Gastric	stomach
22	chr9:6150200-6151400	Weak transcription	Stomach Mucosa	stomach
23	chr9:6151400-6151600	Enhancers	Stomach Mucosa	stomach
24	chr9:6151600-6152000	Flanking Active TSS	Hela-S3	cervix
25	chr9:6151600-6152600	Weak transcription	Stomach Mucosa	stomach
26	chr9:6152000-6152400	Enhancers	Hela-S3	cervix
27	chr9:6152400-6153200	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr9:6152400-6153600	Flanking Active TSS	Hela-S3	cervix
29	chr9:6152400-6154400	Enhancers	HUVEC	blood vessel
30	chr9:6152600-6153400	Enhancers	iPS-18 Cell Line	embryonic stem cell
31	chr9:6152600-6154200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr9:6152600-6154200	Enhancers	Stomach Mucosa	stomach
33	chr9:6152600-6154200	Enhancers	NHEK	skin
34	chr9:6152800-6153200	Enhancers	HUES64 Cell Line	embryonic stem cell
35	chr9:6152800-6153200	Enhancers	iPS-20b Cell Line	embryonic stem cell
36	chr9:6152800-6153200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
37	chr9:6152800-6153200	Enhancers	A549	lung
38	chr9:6153000-6153600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
39	chr9:6153000-6154200	Enhancers	HMEC	breast
40	chr9:6153200-6153600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr9:6153200-6153600	Flanking Active TSS	A549	lung
42	chr9:6153200-6159400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr9:6153600-6155400	Enhancers	Hela-S3	cervix
44	chr9:6153800-6154000	Enhancers	Gastric	stomach
45	chr9:6153800-6154200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
46	chr9:6159400-6159800	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr9:6159800-6160200	ZNF genes & repeats	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
48	chr9:6160200-6173600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr9:6165600-6165800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
50	chr9:6165600-6166200	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links